Description
Semax is a synthetic peptide that has shown promise in improving cognitive ability, reducing mental fatigue, and promoting neuroprotection. This has made it a popular choice for researchers exploring cognitive enhancement and nootropic peptides. Semax has been proven to accelerate the regression of neurological symptoms and significantly increase the number of patients with good recovery. Clinical studies have shown that Semax can accelerate ulcer healing.
Daily Dosage: 500mcg-1mg of Semax, subcutaneously, depending on subject’s responsiveness.
Study Duration: Four to eight weeks; one 30mg vial of Semax provides for 30x 1mg doses or 60x 500mcg doses.
Brain-derived neurotrophic factor (BDNF) plays a key role in regulating the emotional state and cognitive functions of humans and animals, as well as stimulating neurogenesis and synaptic plasticity throughout the brain. Data has shown that Semax administration improves learning in animals and increases BDNF expression and expression of its high-affinity TrkB receptors in the rat hippocampus. In addition, when a proper Semax dosage is administered safely, it increases resistance to hypoxia and improvements in circulation to the brain in experimental animals and humans.
Various studies have shown that a proper Semax dosage improves memory and attention, and has antihypoxic and neuroprotective effects. Acute administration of Semax can play a role in regulating emotional states: one laboratory animal study has found Semax effective in stimulating the activity of dopamine and serotonin in the brain—hormones known for their antidepressant properties. In addition, chronic Semax administration has an anxiolytic effect under normal conditions and can alleviate damage caused by oxidative stress
